Analyst Price Targets — VYNE
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 14, 2024 7:58 am | Joseph Pantginis | H.C. Wainwright | $5.75 | $2.11 | StreetInsider | H.C. Wainwright Reiterates Buy Rating on VYNE Therapeutics (VYNE) |
Latest News for VYNE
VYNE Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Yarrow Bioscience
Aggregate cash dividend of an estimated $16.5 million, or an estimated $0.38 per share Aggregate cash dividend of an estimated $16.5 million, or an estimated $0.38 per share
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for VYNE.
U.S. House Trading
No House trades found for VYNE.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.